{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:06:23Z","timestamp":1744416383688,"version":"3.37.3"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012248","name":"Collaborative Innovation Center for Modern Science and Technology and Industrial Development of Jiangxi Traditional Medicine","doi-asserted-by":"crossref","award":["Guangzhou Traditional Chinese Medicine Office Letter [F2019] 7"],"award-info":[{"award-number":["Guangzhou Traditional Chinese Medicine Office Letter [F2019] 7"]}],"id":[{"id":"10.13039\/501100012248","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Postmenopausal osteoporosis (PMO) is one of the most common systemic bone diseases with a high risk of fracture. Traditional herbal formula Gushukang (GSK) has been used to treat PMO. However, there is no systematic review related to GSK for PMO. The object of this work is to evaluate the efficacy and safety of GSK in the management of PMO.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We will search the PubMed, Embase, MEDLINE, Cochrane Library Central Register of Controlled Trials, China national knowledge infrastructure database (CNKI), Wan fang database, Chongqing VIP information, and SinoMed from their inception to May 2020. All randomized controlled trials (RCTs) of GSK for the treatment of PMO will be included. The improvement of vertebral fracture and bone mineral density (BMD) will be accepted as the primary outcomes. The meta-analyses will be performed by using the RevMan 5.3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study will provide a high-quality comprehensive evaluation of the efficacy and safety of GSK for treating patients with PMO.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The conclusion of our systematic review will provide evidence to judge whether GSK is an effective intervention for patients with PMO.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration number:<\/jats:title>\n            <jats:p>10.17605\/OSF.IO\/MKN3F.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000020908","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T16:25:24Z","timestamp":1593447924000},"page":"e20908","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Gushukang for postmenopausal osteoporosis"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1332-8526","authenticated-orcid":false,"given":"Guangwei","family":"Wang","sequence":"first","affiliation":[{"name":"Guangzhou Orthopedic Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Huo","sequence":"additional","affiliation":[{"name":"Guangzhou Orthopedic Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guocai","family":"Chen","sequence":"additional","affiliation":[{"name":"The Fifth Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayong","family":"He","sequence":"additional","affiliation":[{"name":"Guangzhou Orthopedic Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"R1-20240214","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","article-title":"Use of bone turnover markers in postmenopausal osteoporosis","volume":"5","author":"Eastell","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R2-20240214","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: us preventive services task force recommendation statement","volume":"319","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"R3-20240214","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00198-009-0925-y","article-title":"Osteoporosis in China","volume":"20","author":"Wang","year":"2009","journal-title":"Osteoporos Int"},{"key":"R4-20240214","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2147\/CIA.S190440","article-title":"Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures","volume":"13","author":"Ciubean","year":"2018","journal-title":"Clin Interv Aging"},{"issue":"((5 suppl 51))","key":"R5-20240214","first-page":"S125","article-title":"Mortality and osteoporotic fractures: is the link causal, and is it modifiable?","volume":"26","author":"Teng","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"R6-20240214","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5582\/bst.2017.01216","article-title":"Chinese single herbs and active ingredients for postmenopausal osteoporosis: from preclinical evidence to action mechanism","volume":"11","author":"Lin","year":"2017","journal-title":"Biosci Trends"},{"key":"R7-20240214","doi-asserted-by":"crossref","first-page":"e11659","DOI":"10.1097\/MD.0000000000011659","article-title":"Liuwei Dihuang pill cures postmenopausal osteoporosis with kidney-Yin deficiency","volume":"97","author":"Xu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R8-20240214","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/1381612822666151112150346","article-title":"Mechanism of treatment of kidney deficiency and osteoporosis is similar by traditional Chinese medicine","volume":"22","author":"Wang","year":"2016","journal-title":"Curr Pharm Des"},{"key":"R9-20240214","first-page":"265","article-title":"[Clinical study on effect of gushukang granule in preventing and treating primary osteoporosis]","volume":"21","author":"Li","year":"2001","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"R10-20240214","doi-asserted-by":"crossref","first-page":"153063","DOI":"10.1016\/j.phymed.2019.153063","article-title":"Gushukang inhibits osteocyte apoptosis and enhances BMP-2\/Smads signaling pathway in ovariectomized rats","volume":"64","author":"Chai","year":"2019","journal-title":"Phytomedicine"},{"key":"R11-20240214","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00774-018-0924-1","article-title":"Gushukang exerts osteopreserve effects by regulating vitamin D and calcium metabolism in ovariectomized mice","volume":"37","author":"Li","year":"2019","journal-title":"J Bone Miner Metab"},{"key":"R12-20240214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R13-20240214","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R14-20240214","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"J Clin Epidemiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T16:02:08Z","timestamp":1707926528000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020908"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":14,"journal-issue":{"issue":"27","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020908","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,7,2]]}}}